Atjaunināt sīkdatņu piekrišanu

E-grāmata: Nanopharmaceuticals: Volume 1: Expectations and Realities of Multifunctional Drug Delivery Systems

Edited by (Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany)
  • Formāts: EPUB+DRM
  • Izdošanas datums: 10-Jan-2020
  • Izdevniecība: Elsevier Science Publishing Co Inc
  • Valoda: eng
  • ISBN-13: 9780128177792
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 203,82 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Izdošanas datums: 10-Jan-2020
  • Izdevniecība: Elsevier Science Publishing Co Inc
  • Valoda: eng
  • ISBN-13: 9780128177792
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Nanopharmaceuticals reviews advances in the drug delivery field via nanovehicles or nanocarriers that offer benefits like targeted therapy and serves as a single dose magic bullet for multiple drug delivery with improved drug efficiency at a lower dose, transportation of the drug across physiological barriers as well as reduced drug-related toxicity. The chapters are written by a diverse group of international researchers from industry and academia. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems. Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series: Delivery of Drugs, Volume 2, 9780128177761 Drug Delivery Trends, Volume 3, 9780128178706 Drug Delivery Aspects, Volume 4, 9780128212226
1. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism,
fate and physicochemical properties
J.R. CAMPOS, P. SEVERINO, A. SANTINI, A.M. SILVA, RANJITA SHEGOKAR, S.B.
SOUTO, AND E.B. SOUTO
2. Role of nanocarriers and their surface modification in targeting delivery
of bioactive compounds
HENI RACHMAWATI, ATSARINA LARASATI, ANNIS CATUR ADI, AND RANJITA SHEGOKAR
3. Polymeric nanomicelles as versatile tool for multidrug delivery in
chemotherapy
KOBRA ROSTAMIZADEH AND VLADIMIR P. TORCHILIN
4. Nanoparticulate systems for wound healing
MAHA NASR, RIHAM I. EL-GOGARY, HEND ABD-ALLAH, AND MONA ABDEL-MOTTALEB
5. Solid dispersions: technologies used and future outlook
N.B. JADAV AND A. PARADKAR
6. Nanotoxicity: the impact of increasing drug bioavailability
JUAN BUENO
7. Nanoparticle-based vaccines: opportunities and limitations
DIANA DIAZ-ARÉVALO AND MINGTAO ZENG
8. Lipid nanocarriers for delivery of poorly soluble and poorly permeable
drugs
ANŠELKA B. KOVACEVIC
9. Nose-to-brain drug delivery: an alternative approach for effective brain
drug targeting
AMIT ALEXANDER, MUKTA AGRAWAL, MAHAVIR BHUPAL CHOUGULE, SHAILENDRA SARAF, AND
SWARNLATA SARAF
10. Trends in the intellectual property (IP) landscape of drug delivery
systems: 30 years of growth and evolution
AMANDA STARLING-WINDHOF, ASUR SRINIVASAN, TINA TOMEO, ANNE MARIE CLARK, AND
PETER MATTEI
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)